Vytorin Litigation, Zetia Litigation at The Lanier Law FirmOn March 30, 2008, a group of doctors at one of the country’s largest cardiology conferences released the results of a clinical study that showed the cholesterol-lowering drugs Vytorin and Zetia may not work at all, and in some cases actually made patients’ cholesterol problems worse. The panel of doctors recommended that both drugs should be prescribed only as a last resort. An editorial published the same day in the prestigious New England Journal of Medicine made the same recommendation based on the fact that other cholesterol drugs are cheaper and show proven benefits.
Vytorin, Zetia Background InformationVytorin and Zetia are two of the top-selling drugs in the world, accounting for more than $5 billion in combined sales in 2007 alone. Worldwide, five million people take the heavily advertised drugs, including four million Americans. Vytorin and Zetia are manufactured by the pharmaceutical manufacturing giants Merck and Schering-Plough.
Problems Caused by Vytorin, ZetiaThe Lanier Law Firm is representing Third-Party Payors (health plans, union benefit funds, self-insured employers and others) who paid for Vytorin or Zetia that was used by patients. We intend to prove that Merck & Schering Plough marketed these drugs in a false and misleading manner, thereby creating an enormous artificial demand for Vytorin and Zetia which would not have existed if the defendants had fully and fairly disclosed the truth about their drugs. Please contact us for a free case evaluation.
|
